Development of Polymeric Nanopaclitaxel and Comparison with Free Paclitaxel for Effects on Cell Proliferation of MCF-7 and B16F0 Carcinoma Cells

Yadav, Deepak; Anwar, Mohammad Faiyaz; Garg, Veena; Kardam, Hemant; Beg, Mohd Nadeem; Suri, Suruchi; Gaur, Sikha; Asif, Mohd

추천

검색

자료유형: 학술저널

저자정보: Yadav, Deepak (Drug Standardization Lab, Department of Ilmul-Advia [Pharmacology], Faculty of Medicine) Anwar, Mohammad Faiyaz (Department of Chemistry, Hamdard University) Garg, Veena (Department of Bioscience and Biotechnology, Banasthali University) Kardam, Hemant (Faculty of Science, Hamdard University) Beg, Mohd Nadeem (Drug Standardization Lab, Department of Ilmul-Advia [Pharmacology], Faculty of Medicine) Suri, Suruchi (Nanomedicine Lab, Faculty of Pharmacy, Hamdard University) Gaur, Sikha (Department of Pharmaceutics, PDM College of Pharmacy) Asif, Mohd (Drug Standardization Lab, Department of Ilmul-Advia [Pharmacology], Faculty of Medicine)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제15권 제5호

발행연도: 2014.1

수록면: 2,335 - 2,340 (6page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Paclitaxel is hydrophobic in nature and is recognized as a highly toxic anticancer drug, showing adverse effects in normal body sites. In this study, we developed a polymeric nano drug carrier for safe delivery of the paclitaxel to the cancer that releases the drug in a sustained manner and reduces side effects. N-isopropylacrylamide/vinyl pyrrolidone (NIPAAm/VP) nanoparticles were synthesized by radical polymerization. Physicochemical characterization of the polymeric nanoparticles was conducted using dynamic light scattering, transmission electron microscopy, scanning electron microscopy and nuclear magnetic resonance, which confirmedpolymerization of formulated nanoparticles. Drug release was assessed using a spectrophotometer and cell viability assays were carried out on the MCF-7 breast cancer and B16F0 skin cancer cell lines. NIPAAm/VP nanoparticles demonstrated a size distribution in the 65-108 nm range and surface charge measured -15.4 mV. SEM showed the nanoparticles to be spherical in shape with a slow drug release of ~70% in PBS at $38^{\circ}C$ over 96 h. Drug loaded nanoparticles were associated with increased viability of MCF-7 and B16F0 cells in comparison to free paclitaxel. Nano loaded paclitaxel shows high therapeutic efficiency by sustained release action for the longer period of time, i increasing its efficacy and biocompatibility for human cancer therapy. Therefore, paclitaxel loaded (NIPAAm/VP) nanoparticles may provide opportunities to expand delivery of the drug for clinical selection.

#NIPAAm/VP nanoparticles #paclitaxel #sustain drug delivery #cancer cell lines MCF-7 #B16F0

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요